N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide
C22H24F3N5O3S — CID 26956251
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide
N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide (PubChem CID 26956251) has the molecular formula C22H24F3N5O3S and a molecular weight of 495.53 g/mol. Its IUPAC name is N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide.
Molecular Properties
| Compound Name | N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide |
|---|---|
| PubChem CID | 26956251 |
| Molecular Formula | C22H24F3N5O3S |
| Molecular Weight | 495.53 g/mol |
| Exact Mass | 495.16 |
| IUPAC Name | N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxamide |
| SMILES | CC(C)n1ncc2cc(NC(=O)C3CCN(S(=O)(=O)c4ccccc4C(F)(F)F)CC3)cnc21 |
| InChI | InChI=1S/C22H24F3N5O3S/c1-14(2)30-20-16(12-27-30)11-17(13-26-20)28-21(31)15-7-9-29(10-8-15)34(32,33)19-6-4-3-5-18(19)22(23,24)25/h3-6,11-15H,7-10H2,1-2H3,(H,28,31) |
| InChIKey | KHHVOHKDSMTVBY-UHFFFAOYSA-N |
| XLogP | 4.07 |
| TPSA | 97.19 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 495.53 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 26956251 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.